Use of Cancer Stem Cells to Investigate the Pathogenesis of Colitis-associated Cancer. Issue 4 (April 2016)

• Record Type: Journal Article
• Authors: Davies, Julie M.; Santaolalla, Rebeca; Abreu, Maria T.
• Is Part Of: Inflammatory bowel diseases. Volume 22:Issue 4(2016:Apr.)
• Publication Date: 2016-04
• Subjects: colitis-associated cancer -- stem cells -- inflammation -- enteroid -- colonoid -- APC -- Lgr5 -- β-catenin; Inflammatory bowel diseases -- Periodicals; Colitis, Ulcerative -- Periodicals; Crohn Disease -- Periodicals; Inflammatory Bowel Diseases -- Periodicals; 616.344
• DOI: 10.1097/MIB.0000000000000756
• Languages: English
• ISSNs: 1078-0998

Abstract

Abstract : Abstract: Colitis-associated cancer (CAC) can develop in patients with inflammatory bowel disease with long-term uncontrolled inflammation. The mutational history and tumor microenvironment observed in CAC patients is distinct from that observed in sporadic colon cancer and suggests a different etiology. Recently, much attention has been focused on understanding the cellular origin of cancer and the cancer stem cells, which is key to growth and progression. Cancer stem cells are often chemo-resistant making them attractive targets for improving patient outcomes. New techniques have rapidly been evolving allowing for a better understanding of the normal intestinal stem cell function and behavior in the niche. Use of these new technologies will be crucial to understanding cancer stem cells in both sporadic and CAC. In this review, we will explore emerging methods related to the study of normal and cancer stem cells in the intestine, and examine potential avenues of investigation and application to understanding the pathogenesis of CAC. Abstract : Article first published online 9 March 2016.